176 related articles for article (PubMed ID: 26763851)
1. Effects of antihypertensive drugs losartan and levamlodipine besylate on insulin resistance in patients with essential hypertension combined with isolated impaired fasting glucose.
Xiao WY; Ning N; Tan MH; Jiang XS; Zhou L; Liu L; Yi D; Wei P
Hypertens Res; 2016 May; 39(5):321-6. PubMed ID: 26763851
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the effects of barnidipine+losartan compared with telmisartan+hydrochlorothiazide on several parameters of insulin sensitivity in patients with hypertension and type 2 diabetes mellitus.
Derosa G; Querci F; Franzetti I; Dario Ragonesi P; D'Angelo A; Maffioli P
Hypertens Res; 2015 Oct; 38(10):690-4. PubMed ID: 25994603
[TBL] [Abstract][Full Text] [Related]
3. Effects of losartan and amlodipine alone or combined with simvastatin in hypertensive patients with nonalcoholic hepatic steatosis.
Fogari R; Maffioli P; Mugellini A; Zoppi A; Lazzari P; Derosa G
Eur J Gastroenterol Hepatol; 2012 Feb; 24(2):164-71. PubMed ID: 22081005
[TBL] [Abstract][Full Text] [Related]
4. Losartan elevates the serum high-molecular weight-adiponectin isoform and concurrently improves insulin sensitivity in patients with impaired glucose metabolism.
Nishimura H; Sanaka T; Tanihata Y; Naito T; Higuchi C; Otsuka K
Hypertens Res; 2008 Aug; 31(8):1611-8. PubMed ID: 18971537
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and tolerability of fimasartan, a new angiotensin receptor blocker, compared with losartan (50/100 mg): a 12-week, phase III, multicenter, prospective, randomized, double-blind, parallel-group, dose escalation clinical trial with an optional 12-week extension phase in adult Korean patients with mild-to-moderate hypertension.
Lee SE; Kim YJ; Lee HY; Yang HM; Park CG; Kim JJ; Kim SK; Rhee MY; Oh BH;
Clin Ther; 2012 Mar; 34(3):552-568, 568.e1-9. PubMed ID: 22381711
[TBL] [Abstract][Full Text] [Related]
6. Different actions of losartan and ramipril on adipose tissue activity and vascular remodeling biomarkers in hypertensive patients.
Derosa G; Maffioli P; Ferrari I; Palumbo I; Randazzo S; Fogari E; D'Angelo A; Cicero AF
Hypertens Res; 2011 Jan; 34(1):145-51. PubMed ID: 21107327
[TBL] [Abstract][Full Text] [Related]
7. Effects of rosuvastatin combined with olmesartan, irbesartan, or telmisartan on indices of glucose metabolism in Greek adults with impaired fasting glucose, hypertension, and mixed hyperlipidemia: a 24-week, randomized, open-label, prospective study.
Rizos CV; Milionis HJ; Kostapanos MS; Florentin M; Kostara CE; Elisaf MS; Liberopoulos EN
Clin Ther; 2010 Mar; 32(3):492-505. PubMed ID: 20399986
[TBL] [Abstract][Full Text] [Related]
8. Telmisartan improves vascular function independently of metabolic and antihypertensive effects in hypertensive subjects with impaired glucose tolerance.
Perl S; Schmölzer I; Sourij H; Pressl H; Eder M; Zweiker R; Wascher TC
Int J Cardiol; 2010 Mar; 139(3):289-96. PubMed ID: 19118910
[TBL] [Abstract][Full Text] [Related]
9. Blood pressure reduction and antihypertensive medication use in the losartan intervention for endpoint reduction in hypertension (LIFE) study in patients with hypertension and left ventricular hypertrophy.
Devereux RB; de Faire U; Fyhrquist F; Harris KE; Ibsen H; Kjeldsen SE; Lederballe-Pedersen O; Lindholm LH; Nieminen MS; Omvik P; Oparil S; Wedel H; Hille DA; Dahlöf B
Curr Med Res Opin; 2007 Feb; 23(2):259-70. PubMed ID: 17288679
[TBL] [Abstract][Full Text] [Related]
10. The effects of a low-salt diet on the efficacy of different antihypertensive drug regimens.
Wang J; Qiu B; Du JL; Deng SB; Liu YJ; She Q
J Clin Pharmacol; 2015 Dec; 55(12):1362-8. PubMed ID: 26053853
[TBL] [Abstract][Full Text] [Related]
11. Losartan reduces insulin resistance by inhibiting oxidative stress and enhancing insulin signaling transduction.
Pan Y; Qiao QY; Pan LH; Zhou DC; Hu C; Gu HF; Fu SK; Liu XL; Jin HM
Exp Clin Endocrinol Diabetes; 2015 Mar; 123(3):170-7. PubMed ID: 25502581
[TBL] [Abstract][Full Text] [Related]
12. Quantification of pedal edema during treatment with S(-)-amlodipine nicotinate versus amlodipine besylate in female Korean patients with mild to moderate hypertension: a 12-week, multicenter, randomized, double-blind, active-controlled, phase IV clinical trial.
Oh GC; Lee HY; Kang HJ; Zo JH; Choi DJ; Oh BH
Clin Ther; 2012 Sep; 34(9):1940-7. PubMed ID: 22925988
[TBL] [Abstract][Full Text] [Related]
13. [The effect of treatment with enalapril versus losartan on levels of insulin resistance in patients with essential hypertension].
Akel A; Wiecek A; Nowicki M; Kokot F
Pol Arch Med Wewn; 2000; 103(3-4):123-31. PubMed ID: 11236238
[TBL] [Abstract][Full Text] [Related]
14. Circulating levels of endothelin-1 during acute hyperinsulinemia in patients with essential hypertension treated with type 1 angiotensin receptor antagonist or placebo.
Seljeflot I; Moan A; Aspelin T; Tønnessen T; Kjeldsen SE; Arnesen H
Metabolism; 1998 Mar; 47(3):292-6. PubMed ID: 9500565
[TBL] [Abstract][Full Text] [Related]
15. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
Pessina AC; Ciccariello L; Perrone F; Stoico V; Gussoni G; Scotti A; Muggeo M
Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Fixed-dose Combinations of Amlodipine/Losartan Potassium/Chlorthalidone and Amlodipine/Losartan Potassium in Patients With Stage 2 Hypertension Inadequately Controlled With Amlodipine/Losartan Potassium: A Randomized, Double-blind, Multicenter, Phase III Study.
Hong SJ; Jeong HS; Han SH; Chang KY; Hong BK; Lee BK; Chae SC; Kim WS; Park CG; Heo JH; Lee SU; Kim YD; Kim KS; Choi JH; Kang HJ; Kim JJ; Kang SM; Choi YJ; Shin JH; Chun KJ; Shin DG; Park SH; Kwan J; Choi YJ; Jeong MH; Chae JK; Kim DW; Cho JR; Han KR; Won KH; Park SH; Lee SK; Kim SH; Jung J; Kim CH
Clin Ther; 2017 Oct; 39(10):2049-2060. PubMed ID: 28939406
[TBL] [Abstract][Full Text] [Related]
17. The antihypertensive efficacy of losartan and amlodipine assessed with office and ambulatory blood pressure monitoring. Canadian Cozaar Hyzaar Amlodipine Trial Study Group.
Wilson TW; Lacourcière Y; Barnes CC
CMAJ; 1998 Sep; 159(5):469-76. PubMed ID: 9757170
[TBL] [Abstract][Full Text] [Related]
18. Clinic blood pressure responses to two amlodipine salt formulations, adipate and besylate, in adult Korean patients with mild to moderate hypertension: a multicenter, randomized, double-blind, parallel-group, 8-week comparison.
Lee HY; Kang HJ; Koo BK; Oh BH; Heung-Sun K; Kim KS; Seo HS; Ro YM; Kang JH; Woong CJ; Joo SJ; Kim MH; Joon-Han S; Yoon J; Park SH; Jin-Ok J; Ju AK; Chong-Yun R; Yeon KJ; Park KM; Lim DK; Park SY;
Clin Ther; 2005 Jun; 27(6):728-39. PubMed ID: 16117979
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of chlorthalidone/amiloride versus losartan in patients with stage I hypertension: results from the PREVER-treatment randomized trial.
Fuchs FD; Scala LC; Vilela-Martin JF; de Mello RB; Mosele F; Whelton PK; Poli-de-Figueiredo CE; de Alencastro PR; E Silva RP; Gus M; Bortolotto LA; Schlatter R; Cesarino EJ; Castro I; Neto JA; Chaves H; Steffens AA; Alves JG; Brandão AA; de Sousa MR; Jardim PC; Moreira LB; Franco RS; Gomes MM; Neto AA; Fuchs FC; Filho DC; Nóbrega AC; Nobre F; Berwanger O; Fuchs SC
J Hypertens; 2016 Apr; 34(4):798-806. PubMed ID: 26938814
[TBL] [Abstract][Full Text] [Related]
20. Improved insulin sensitivity with the angiotensin II-receptor blocker losartan in patients with hypertension and other cardiovascular risk factors.
Aksnes TA; Reims HM; Guptha S; Moan A; Os I; Kjeldsen SE
J Hum Hypertens; 2006 Nov; 20(11):860-6. PubMed ID: 16988754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
